Skip to main content

Added Value of the Neuropsychological Evaluation for Diagnosis and Research of Atypical Parkinsonian Disorders

  • Chapter
Atypical Parkinsonian Disorders

Part of the book series: Current Clinical Neurology ((CCNEU))

Abstract

Diseases with movement disorders may be difficult to diagnose, both at the onset when motor symptoms are mild and not sufficiently specific (e.g., difficulty in manipulating objects), or at the end stage when distinctive motor signs are diluted into a severe and polymorphous clinical picture (e.g., gait disorder with postural instability and cognitive decline in aged patients). Erroneous diagnoses are frequent (1,2), even in the most common idiopathic Parkinson’s disease (PD) (3). Some of these errors may be avoided if the cognitive dysfunctions that often accompany these diseases are included in the diagnostic criteria.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 379.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP International Workshop. Neurology 1996;47:1–9.

    PubMed  CAS  Google Scholar 

  2. Litvan I, Agid Y, Goetz C, et al. Accuracy of clinical diagnosis of corticobasal degeneration. Neurology 1997;48:119–125.

    PubMed  CAS  Google Scholar 

  3. Hughes AJ, Daniel SE, Kilford L, Lees AJ. The accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinicopathological study. J Neurol Neurosurg Psychiatry 1992;55:181–184.

    PubMed  CAS  Google Scholar 

  4. Troster AI, Woods SP, Fields JA, et al. Neuropsychological deficits in essential tremor: an expression of cerebellothalamo-cortical pathophysiology? Eur J Neurol 2002;9:143–151.

    Article  PubMed  CAS  Google Scholar 

  5. Mattis S. Dementia Rating Scale. Odessa, FL: Psychological Assessment Resources Inc., 1988.

    Google Scholar 

  6. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a Frontal Assessment Battery at bedside. Neurology 2000;55:1621–1626.

    PubMed  CAS  Google Scholar 

  7. Nelson HE. A modified Card Sorting Test sensitive to frontal lobe defect. Cortex 1976;12:313–324.

    PubMed  CAS  Google Scholar 

  8. Benton AL. Differential behavioral effects in frontal lobe disease. Neuropsychologia 1968;6:53–60.

    Article  Google Scholar 

  9. Reitan RM. Validity of the Trail Making Test as an indication of organic brain damage. Percept Mot Skills 1958;8:271–276.

    Article  Google Scholar 

  10. Golden CJ. Stroop Color and Word Test. Chicago: Stoelting Company, 1978.

    Google Scholar 

  11. Luria AR. Higher Cortical Functions in Man. New York, NY: Basic Books, 1966.

    Google Scholar 

  12. Lhermitte F, Pillon B, Serdaru M. Human autonomy and the frontal lobes, I: imitation and utilization behaviors: a neuropsychological study of 75 patients. Ann Neurol 1986;19:326–334.

    Article  PubMed  CAS  Google Scholar 

  13. Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test: Research Edition. New York: Psychological Corporation, 1987.

    Google Scholar 

  14. Grober E, Buschke H. Genuine memory deficits in dementia. Dev Neuropsychol 1987;3:13–36.

    Article  Google Scholar 

  15. Goodglass H, Kaplan E. The Assessment of Aphasia and Related Disorders. Philadelphia: Lea & Febiger, 1976.

    Google Scholar 

  16. Heilman KM, Gonzalez Rothi LJ. Apraxia. In: Heilman KM, Valenstein E, eds. Clinical Neuropsychology, 2nd ed. Oxford: Oxford University Press, 1985:131–150.

    Google Scholar 

  17. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308–2314.

    PubMed  CAS  Google Scholar 

  18. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association, 1994.

    Google Scholar 

  19. Quinn N, Critchley P, Marsden CD. Young onset Parkinson’s disease. Mov Disord 1987; 2: 73–91.

    Article  PubMed  CAS  Google Scholar 

  20. Cooper JA, Sagar HJ, Jordan N, Harvey NS, Sullivan EV. Cognitive impairment in early untreated Parkinson’s disease and its relationship to motor disability. Brain 1991;114:2095–2122.

    Article  PubMed  Google Scholar 

  21. Robbins TW, James M, Lange KW, Owen AM, Quinn NA, Marsden CD. Cognitive performance in Multiple System Atrophy. Brain 1992;115:271–291.

    Article  PubMed  Google Scholar 

  22. Pillon B, Gouider-Khouja N, Deweer B, et al. Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson’s disease and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1995; 58:174–179.

    PubMed  CAS  Google Scholar 

  23. Zetusky WJ, Jankovic J, Pirozzolo FJ. The heterogeneity of Parkinson’s disease: clinical and prognostic implications. Neurology 1985;35:522–526.

    PubMed  CAS  Google Scholar 

  24. Maher ER, Lees AJ. The clinical features and natural history of the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1986;36:1005–1008.

    PubMed  CAS  Google Scholar 

  25. Pillon B, Dubois B, Ploska A, Agid Y. Severity and specificity of cognitive impairment in Alzheimer’s, Huntington’s, and Parkinson’s diseases and progressive supranuclear palsy. Neurology 1991;41: 634–643.

    PubMed  CAS  Google Scholar 

  26. Wenning GK, Litvan I, Jankovic J, et al. Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J Neurol Neurosurg Psychiatry 1998;64:184–189.

    PubMed  CAS  Google Scholar 

  27. Byrne EJ, Lennox G, Lowe J, Godwin-Austen RB. Diffuse Lewy body disease: clinical features in 15 cases. J Neurol Neurosurg Psychiatry 1989;52:709–717.

    PubMed  CAS  Google Scholar 

  28. Tounsi H, Deweer B, Ergis AM, et al. Sensitivity to semantic cuing: An index of episodic memory dysfunction in early Alzheimer’s disease. Alzheimer disease and associated disorders 1999;13:38–46.

    Article  PubMed  CAS  Google Scholar 

  29. Pillon B, Deweer B, Michon A, Malpand C, Agid Y, Dubois B. Are explicit memory disorders of progressive supranuclear palsy related to damage to striatofrontal circuits? Comparison with Alzheimer’s, Parkinson’s, and Huntington’s diseases. Neurology 1994;44:1254–1270.

    Google Scholar 

  30. Taylor AE, Saint-Cyr JA, Lang AE. Memory and learning in early Parkinson’s disease: evidence for a “frontal lobe syndrome.” Brain Cogn 1990;13:211–232.

    Article  PubMed  CAS  Google Scholar 

  31. Buytenhuijs EJ, Berger JC, van Spaendonck KP, Horstink MW, Borm GF, Cools AR. Memory and learning strategies in patients with Parkinson’s disease. Neuropsychologia 1994;32:335–342.

    Article  PubMed  CAS  Google Scholar 

  32. Pillon B, Blin J, Vidailhet M, et al. The neuropsychological pattern of corticobasal degeneration. Comparison with progressive supranuclear palsy and Alzheimer’s disease. Neurology 1995; 45:1477–1483.

    PubMed  CAS  Google Scholar 

  33. Massman PJ, Kreiter KT, Jankovic J, Doody RS. Neuropsychological functioning in cortical-basal ganglionic degeneration: differenciation from Alzheimer’s disease. Neurology 1996;46:720–726.

    PubMed  CAS  Google Scholar 

  34. Connor DJ, Salmon DP, Sandy TJ, Galasko D, Hansen LA, Thal L. Cognitive profiles of autopsy-confirmed Lewy body variant vs pure Alzheimer’s disease. Arch Neurol 1998; 55:994–1000.

    Article  PubMed  CAS  Google Scholar 

  35. Brown RG, Marsden CD. “Subcortical dementia”: the neuropsychological evidence. Neurosci 1988; 25:363–387.

    Article  CAS  Google Scholar 

  36. Leiguarda R, Merello M, Nouzeilles MI, Balej J, Rivero A, Nagues M. Limb-kinetic apraxia in corticobasal degeneration: clinical and kinematic features. Mov Disord 2003;18:49–59.

    Article  PubMed  Google Scholar 

  37. Maher ER, Smith EM, Lees AJ. Cognitive deficits in the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). J Neurol Neurosurg Psychiatry 1985;48:1234–1239.

    PubMed  CAS  Google Scholar 

  38. Ross GW, Mahler ME, Cummings JL. The dementia syndromes of Parkinson’s disease: cortical and subcortical features. In: Huber SJ, Cummings JL, eds. Parkinson’s Disease: Neurobehavioral Aspects. Oxford: Oxford University Press,1992:132–148.

    Google Scholar 

  39. Taylor AE, Saint-Cyr JA, Lang AE. Frontal lobe dysfunction in Parkinson’s disease. Brain 1986; 109:845–883.

    Article  PubMed  Google Scholar 

  40. Owen AM, Robbins TW. Comparative neuropsychology of Parkinsonian syndromes. In: Wolters EC, Scheltens P, eds. Mental Dysfunction in Parkinson’s Disease. Proceedings of the European Congress on Mental Dysfunction in Parkinson’s Disease held in Amsterdam on 20–23 October 1993. Amsterdam: Vrije Universiteit, 1993: 221–241.

    Google Scholar 

  41. Cummings JL. Psychosis in basal ganglia disorders. In: E Wolters E, Scheltens P, eds. Mental Dysfunction in Parkinson’s Disease. Proceedings of the European Congress on Mental Dysfunction in Parkinson’s Disease held in Amsterdam on 20–23 October 1993. Amsterdam: Vrije Universiteit, 1993: 257–268.

    Google Scholar 

  42. Litvan I, Paulsen JS, Mega MS, Cummings JL. Neuropsychiatric assessment of patients with hyperkinetic and hypokinetic movement disorders. Arch Neurol 1998;55:1313–1319

    Article  PubMed  CAS  Google Scholar 

  43. Litvan I, Mega MS, Cummings JL, Fairbanks L. Neuropsychiatric aspects of progressive supranuclear palsy. Neurology 1996;47:1184–1189.

    PubMed  CAS  Google Scholar 

  44. Aarsland D, Ballard G, Larsen JP, McKeith I. A comparative study of psychiatric symptoms in dementia with diffuse Lewy body disease and Parkinson’s disease with and without dementia. Int J Geriatr Psychiatry 2001; 16:528–536.

    Article  PubMed  CAS  Google Scholar 

  45. Cummings JL, Litvan I. Neuropsychiatric aspects of corticobasal degeneration. In: Litvan I, Goetz CG, Lang AE, eds. Corticobasal Degeneration. Advances in Neurology, vol. 82. Philadelphia: Lippincott, Williams & Wilkins, 2000:147–152.

    Google Scholar 

  46. Pillon B, Boller F, Levy R, Dubois B. Cognitive deficits and dementia in Parkinson’s disease. In: Boller F, Grafman J (eds.). Handbook of Neuropsychology, vol 6. Aging and Dementia. Amsterdam: Elsevier, 2001:311–371.

    Google Scholar 

  47. Slaughter JR, Slaughter KA, Nichols D, Holmes SE, Martens MP. Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson’s disease. J Neuropsychiatry Clin Neurosci 2001;13: 187–196.

    PubMed  CAS  Google Scholar 

  48. Pluck GC, Brown RG. Apathy in Parkinson’s disease. J Neurol Neurosurg Psychiatry 2002;73: 636–642.

    Article  PubMed  CAS  Google Scholar 

  49. Czernecki V, Pillon B, Houeto JL, Pachon JB, Levy R, Dubois B. Motivation, reward, and Parkinson’s disease: influence of dopatherapy. Neuropsychologia 2002;40:2257–2267.

    Article  PubMed  CAS  Google Scholar 

  50. Katzen HL, Levin BE, Llabre ML. Age of disease onset influences cognition in Parkinson’s disease. J Int Neuropsychol Soc 1998;4:285–290.

    PubMed  CAS  Google Scholar 

  51. Meco G, Gasparini M, Doricchi F. Attentional functions in multiple system atrophy and Parkinson’s disease. J Neurol Neurosurg Psychiatry 1996;60:393–398.

    PubMed  CAS  Google Scholar 

  52. Soliveri P, Monza D, Paridi D, et al. Neuropsychological follow-up in patients with Parkinson’s disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 2000;69:313–318.

    Article  PubMed  CAS  Google Scholar 

  53. Brown RG, Pillon B, Uttner I, and Members of the Neuropsychology Working Group and NNIPPS Consortium, France, Germany, UK. Cognitive function in patients with progressive supranuclear palsy and multiple system atrophy. The Movement Disorder Society, 7th International Congress of Parkinson’s disease and Movement Disorders, November 2002. Book of Abstracts, 2002, P706.

    Google Scholar 

  54. Ghika J. Mood and behavior in disorders of the basal ganglia. In: Bogousslavsky J, Cummings JL, eds. Behavior and Mood Disorders in Focal Brain Lesions. Cambridge: Cambridge University Press, 2000:122–200.

    Google Scholar 

  55. Dubois B, Pillon B, Legault F, Ajid Y, Lhermitte F. Slowing of cognitive processing in progressive supranuclear palsy. A comparison with Parkinson’s disease. Arch Neurol 1988;45:1194–1199.

    PubMed  CAS  Google Scholar 

  56. Johnson R. Event-related brain potentials. In: Litvan I, Agid Y, eds. Progressive Supranuclear Palsy. Oxford: Oxford University Press, 1992:122–154.

    Google Scholar 

  57. Grafman J, Litvan I, Stark M. Neuropsychological features of progressive supranuclear palsy. Brain Cogn 1995;28:311–320.

    Article  PubMed  CAS  Google Scholar 

  58. Esmonde T, Giles E, Xuereb J, Hodges J. Progressive supranuclear palsy presenting with dynamic aphasia. J Neurol Neurosurg Psychiatry 1996;60:403–410.

    Article  PubMed  CAS  Google Scholar 

  59. Pharr V, Uttl B, Stark M, Litvan I, Fantie B, Grafman J. Comparison of apraxia in corticobasal degeneration and progressive supranuclear palsy. Neurology 2001;56:957–963.

    PubMed  CAS  Google Scholar 

  60. Dubois B, Défontaines B, Deweer B, Malapani C, Pillon B. Cognitive and behavioral changes in patients with focal lesions of the basal ganglia. In: Weiner WJ, Lang AE, eds. Behavioral Neurology of Movement Disorders. Advances in Neurology, vol. 65. New York: Raven, 1995: 29–41.

    Google Scholar 

  61. Slachevsky A, Pillon B, Beato R, et al. The “Signe de l’Applaudissement” in PSP. American Academy of Neurology 54th Annual Meeting, Denver, April 13–20, 2002. Neurology 2002;58(Suppl 3): P06.139.

    Google Scholar 

  62. Kertez A, Martinez-Lage P, Davidson W, Munoz DJ. The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia. Neurology 2000;55:1368–1375.

    Google Scholar 

  63. Bergeron C, Davis A, Lang AE. Corticobasal ganglionic degeneration and progressive supranuclear palsy presenting with cognitive decline. Brain Pathology 1998;8:355–365.

    Article  PubMed  CAS  Google Scholar 

  64. Lang AE, Maragonore D, Marsden CD, et al. Movement Disorder Society Symposium on cortico-basal ganglionic degeneration (CBGD) and its relationship to other asymmetrical cortical degeneration syndromes. Mov Disord 1996; 11:346–357.

    Article  Google Scholar 

  65. Leiguarda R, Lees AJ, Merello M, Starkstein S, Marsden CD. The nature of apraxia in corticobasal degeneration. J Neurol Neurosurg Psychiatry 1994;57:455–459.

    PubMed  CAS  Google Scholar 

  66. Spatt J, Bak T, Bozeat S, Patterson K, Hodges JR. Apraxia, mechanical problem solving and semantic knowledge: contributions to object usage in corticobasal degeneration. J Neurol 2002;249:601–608.

    Article  PubMed  Google Scholar 

  67. Frattali CM, Grafman J, Patronas N, Makhlouf MS, Litvan I. Language disturbances in corticobasal degeneration. Neurology 2000;54:990–992.

    PubMed  CAS  Google Scholar 

  68. Grimes DA, Lang AE, Bergeron C. Dementia is the most common presentation of corticobasal ganglionic degeneration. Neurology 1999;53:1969–1974.

    PubMed  CAS  Google Scholar 

  69. Barber R, Panikkar A, McKeith IG. Dementia with Lewy bodies: diagnosis and management. Int J Geriatr Psychiatry 2001;16(Suppl 1):12–18.

    Article  Google Scholar 

  70. Gnanalingham K, Byrne E, Thornton A, Samabrook MA, Bannister P. Motor and cognitive function in Lewy body dementia: comparison with Alzheimer’s and Parkinson’s disease. J Neurol Neurosurg Psychiatry 1997; 62:243–252.

    PubMed  CAS  Google Scholar 

  71. Ballard CG, Aarsland D, McKeith I, et al. Fluctuations in attention: PD dementia vs DLB with parkinsonism. Neurology 2002;59:1714–1720.

    PubMed  CAS  Google Scholar 

  72. Aarsland D, Litvan I, Salmon D, Galasko D, Wentzel-larsen T, Larsen JP. Performance on the dementia rating scale in Parkinson’s disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer’s disease. J Neurol Neurosurg Psychiatry 2003;74:1215–1220.

    Article  PubMed  CAS  Google Scholar 

  73. Apaydin H, Ahlskog JE, Parisi JE, Boeve BF, Dickson DW. Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. Arch Neurol 2002;59:102–112.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Dubois, B., Pillon, B. (2005). Added Value of the Neuropsychological Evaluation for Diagnosis and Research of Atypical Parkinsonian Disorders. In: Litvan, I. (eds) Atypical Parkinsonian Disorders. Current Clinical Neurology. Humana Press. https://doi.org/10.1385/1-59259-834-X:185

Download citation

  • DOI: https://doi.org/10.1385/1-59259-834-X:185

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-331-2

  • Online ISBN: 978-1-59259-834-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics